
Sino Biological/INSIG1 cDNA ORF Clone, Human, untagged/1/HG18790-UT
商品编号:
HG18790-UT
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
INSIG1 cDNA ORF Clone, Human, untagged: General Information
Gene
Species
Human
NCBI Ref Seq
NM_005542.4
RefSeq ORF Size
834 bp
Description
Full length Clone DNA of Human insulin induced gene 1
Plasmid
Promoter
Enhanced CMV mammalian cell promoter
Vector
pCMV3-untagged
Sequencing Primers
T7(TAATACGACTCACTATAGGG) BGH(TAGAAGGCACAGTCGAGG)
Quality Control
The plasmid is confirmed by full-length sequencing.
Screening
Antibiotic in E.coli
Ampicillin
Antibiotic in Mammalian cell
Hygromycin
Application
Stable or Transient mammalian expression
Storage & Shipping
Shipping
Each tube contains lyophilized plasmid.
Storage
The lyophilized plasmid can be stored at ambient temperature for three months.
More Information About INSIG1
Entrez Gene ID
3638
INSIG1 cDNA ORF Clone, Human, untagged: Synonyms
CL-6 cDNA ORF Clone, Human; CL6 cDNA ORF Clone, Human
INSIG1 cDNA ORF Clone, Rat,Related Products
- INSIG1 Lentiviral cDNA ORF Clone, Rat, C-GFPSpark® tagRG83659-ACGLN
- INSIG1 cDNA ORF Clone in Cloning Vector, RatRG83659-U
- Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathwayAuthorZheng, ZG;Zhu, ST;Cheng, HM;Zhang, X;Cheng, G;Thu, PM;Wang, SP;Li, HJ;Ding, M;Qiang, L;Chen, XW;Zhong, Q;Li, P;Xu, X;Year2020JournalAutophagyPubMed ID: 32432943FoldedExpand
- Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathwayAuthorZheng, ZG;Zhu, ST;Cheng, HM;Zhang, X;Cheng, G;Thu, PM;Wang, SP;Li, HJ;Ding, M;Qiang, L;Chen, XW;Zhong, Q;Li, P;Xu, X;Year2020JournalAutophagyPubMed ID: 32432943FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们